The outcome of the axillofemoral bypass: a retrospective analysis of 45 patients.
OBJECTIVE
This study was designed to retrospectively analyze outcomes of axillofemoral bypass (AxFB) operations performed in patients with severe comorbidities.


METHODS
All patients (n = 45) who received an AxFB between 1990 and 2005 for aortoiliac occlusive disease (AIOD, n = 35) or infectious aortic disease (IAD, n = 10) were included. Information on patency of the bypass and mortality was retrieved from patient records. A Kaplan-Meier survival analysis was performed to illustrate survival rates, limb salvage, and primary and secondary patency.


RESULTS
Included patients had several comorbidities and a high operative risk. In this group, a 30-day mortality rate of 20% was found: 17% for the AIOD group, and 30% for the IAD group. During 5-year follow-up 20 patients died, of which 15 during the first year after operation. Survival rates were at 64 and 41% at 1 and 5 years and limb salvage rates were 84% for both these years. Primary patency rates at 1 and 5 years were 72 and 58%, respectively, and secondary patency rates were 86% at both time points.


CONCLUSIONS
High mortality rates were found in AIOD or IAD patients who received an AxFB. However, for high-risk patients with an already reduced life expectancy, the AxFB remains an alternative with acceptable patency rates.
Liedenbaum
Marjolein H
MH
Department of Radiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Verdam
Froukje J
FJ
Spelt
David
D
de Groot
Hans G W
HG
van der Waal
Jan
J
van der Laan
Lijckle
L
D000368:Aged; D000369:Aged, 80 and over; D001018:Aortic Diseases / Q000453:epidemiology / Q000601:surgery*; D001157:Arterial Occlusive Diseases / Q000453:epidemiology / Q000601:surgery; D001366:Axillary Artery / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation; D015897:Comorbidity; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D053208:Kaplan-Meier Estimate; D023821:Limb Salvage; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014654:Vascular Patency
J Vasc Surg. 1996 Feb;23(2):263-9; discussion 269-71
8637103
J Vasc Surg. 1999 Jul;30(1):76-83
10394156
J Cardiovasc Surg (Torino). 1990 May-Jun;31(3):327-32
2370266
Arch Surg. 2002 Dec;137(12):1364-7; discussion 1367-8
12470102
Br J Anaesth. 1996 Aug;77(2):217-22
8881629
J Vasc Surg. 2004 May;39(5):1009-17
15111853
Am J Surg. 1999 Aug;178(2):136-40
10487266
Vascular. 2004 May-Jun;12(3):171-8
15586525
Am J Surg. 2000 Aug;180(2):100-3
11044521
J Vasc Surg. 1997 Oct;26(4):558-69
9357455
J Vasc Surg. 1999 Dec;30(6):1077-83
10587392
J Vasc Surg. 2000 Sep;32(3):451-9; discussion 460-1
10957651
Eur J Vasc Endovasc Surg. 2003 Mar;25(3):240-5
12623336
J Vasc Surg. 1992 Jun;15(6):952-62; discussion 962-3
1597893
Eur J Vasc Surg. 1991 Apr;5(2):179-86
1828041
J Cardiovasc Surg (Torino). 2000 Dec;41(6):905-10
11232974
Lancet. 2000 Jan 29;355(9201):346-51
10665553
J Vasc Surg. 2006 Jun;43(6):1166-74
16765233
Ann Chir Gynaecol. 1999;88(4):269-75
10661822
Med Eng Phys. 2006 Apr;28(3):251-8
16029954